• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[西班牙传染病与临床微生物学会(SEIMC)发布的曲霉菌属及其他真菌所致侵袭性真菌病治疗指南。2011年更新版]

[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update].

作者信息

Fortún Jesús, Carratalá Jordi, Gavaldá Joan, Lizasoain Manuel, Salavert Miguel, de la Cámara Rafael, Borges Marcio, Cervera Carlos, Garnacho José, Lassaleta Álvaro, Lumbreras Carlos, Sanz Miguel Ángel, Ramos José T, Torre-Cisneros Julián, Aguado José M, Cuenca-Estrella Manuel

机构信息

Servicio de Enfermedades Infecciosas, Hospital Universitario Ramón y Cajal, Madrid, Spain.

出版信息

Enferm Infecc Microbiol Clin. 2011 Jun-Jul;29(6):435-54. doi: 10.1016/j.eimc.2011.01.010. Epub 2011 Apr 6.

DOI:10.1016/j.eimc.2011.01.010
PMID:21474210
Abstract

The guidelines on the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) are presented. These recommendations are focused on four clinical categories: oncology-haematology patients, solid organ transplant recipients, patients admitted to intensive care units, and children. An extensive review is made of therapeutical advances and scientific evidence in these settings. These guidelines have been prepared according the SEIMC consensus rules by a working group composed of specialists in infectious diseases, clinical microbiology, critical care medicine, paediatrics and oncology-haematology. Specific recommendations on the prevention of fungal infections in these patients are included.

摘要

西班牙传染病与临床微生物学会(SEIMC)发布了关于曲霉属和其他真菌所致侵袭性真菌病的治疗指南。这些建议聚焦于四个临床类别:肿瘤血液学患者、实体器官移植受者、重症监护病房患者以及儿童。对这些情况下的治疗进展和科学证据进行了广泛综述。这些指南是由传染病、临床微生物学、重症医学、儿科学和肿瘤血液学领域的专家组成的工作组根据SEIMC共识规则制定的。其中还包括了针对这些患者预防真菌感染的具体建议。

相似文献

1
[Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update].[西班牙传染病与临床微生物学会(SEIMC)发布的曲霉菌属及其他真菌所致侵袭性真菌病治疗指南。2011年更新版]
Enferm Infecc Microbiol Clin. 2011 Jun-Jul;29(6):435-54. doi: 10.1016/j.eimc.2011.01.010. Epub 2011 Apr 6.
2
[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update].[侵袭性念珠菌病及其他酵母菌感染的治疗指南。西班牙传染病与临床微生物学会(SEIMC)。2010年更新版]
Enferm Infecc Microbiol Clin. 2011 May;29(5):345-61. doi: 10.1016/j.eimc.2011.01.008. Epub 2011 Apr 2.
3
[Fungal infections in transplantation patients].[移植患者中的真菌感染]
Recenti Prog Med. 2003 Nov;94(11):516-28.
4
Management of mycoses in surgical patients -- review of the literature.外科患者真菌病的管理——文献综述
Eur J Med Res. 2002 May 31;7(5):200-26.
5
[Recommendations of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the prevention of invasive fungal infection due to filamentous fungi].[西班牙传染病与临床微生物学会(SEIMC)关于预防丝状真菌引起的侵袭性真菌感染的建议]
Enferm Infecc Microbiol Clin. 2010 Mar;28(3):172.e1-172.e21. doi: 10.1016/j.eimc.2009.11.007. Epub 2010 Mar 4.
6
[Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 update].[西班牙临床微生物学和传染病学会(SEIMC)侵袭性真菌感染诊断指南。2010年更新版]
Enferm Infecc Microbiol Clin. 2011 Jan;29(1):39.e1-15. doi: 10.1016/j.eimc.2010.08.005. Epub 2010 Dec 22.
7
Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.危重症患者真菌性呼吸道感染的流行病学、诊断与治疗
Rev Esp Quimioter. 2013 Jun;26(2):173-88.
8
Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.器官移植受者中的机会性丝状真菌感染:非曲霉菌丝状真菌的重要性日益凸显
Clin Infect Dis. 2003 Jul 15;37(2):221-9. doi: 10.1086/375822. Epub 2003 Jul 9.
9
Fungal infections after lung transplantation.肺移植后的真菌感染
Transplant Rev (Orlando). 2008 Apr;22(2):89-104. doi: 10.1016/j.trre.2007.12.007.
10
Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients.实体器官移植受者侵袭性真菌感染的诊断、预防和治疗的意大利指南。
Transplant Proc. 2011 Jul-Aug;43(6):2463-71. doi: 10.1016/j.transproceed.2011.06.020.

引用本文的文献

1
What do We Know about Cryptic Aspergillosis?我们对隐匿性曲霉病了解多少?
Microorganisms. 2024 Apr 28;12(5):886. doi: 10.3390/microorganisms12050886.
2
Randomised multicentre clinical trial to evaluate voriconazole pre-emptive genotyping strategy in patients with risk of aspergillosis: vorigenipharm study protocol.评估伏立康唑抢先基因分型策略在曲霉病风险患者中的随机多中心临床试验:伏立康唑基因研究方案
BMJ Open. 2020 Oct 1;10(10):e037443. doi: 10.1136/bmjopen-2020-037443.
3
Levels of evidence supporting clinical practice guidelines on invasive aspergillosis.
支持侵袭性曲霉病临床实践指南的证据级别。
Eur J Clin Microbiol Infect Dis. 2020 May;39(5):903-913. doi: 10.1007/s10096-019-03794-7. Epub 2020 Jan 3.
4
Clinical practice update of antifungal prophylaxis in immunocompromised children.免疫功能低下儿童抗真菌预防的临床实践更新
Rev Esp Quimioter. 2019 Oct;32(5):410-425. Epub 2019 Sep 11.
5
High-Resolution Melting Assay for Genotyping Variants of the CYP2C19 Enzyme and Predicting Voriconazole Effectiveness.用于 CYP2C19 酶基因变异型基因分型的高分辨率熔解分析及预测伏立康唑疗效。
Antimicrob Agents Chemother. 2019 May 24;63(6). doi: 10.1128/AAC.02399-18. Print 2019 Jun.
6
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden.瑞典伊曲康唑与伏立康唑治疗疑似侵袭性曲霉病患者的成本效果分析。
BMC Infect Dis. 2019 Feb 11;19(1):134. doi: 10.1186/s12879-019-3683-2.
7
Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China.中国发热性中性粒细胞减少血液恶性肿瘤患者的抢先抗真菌治疗
Med Sci Monit. 2016 Nov 7;22:4226-4232. doi: 10.12659/msm.897596.
8
Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.德国和西班牙血液系统疾病患者侵袭性曲霉菌病初始治疗中伏立康唑与两性霉素 B 脂质体的成本分析。
BMC Pharmacol Toxicol. 2014 Sep 24;15:52. doi: 10.1186/2050-6511-15-52.
9
The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.活性氧的产生是两性霉素B抗致病性酵母的一种普遍作用机制,并且有助于该药物的杀菌效果。
Antimicrob Agents Chemother. 2014 Nov;58(11):6627-38. doi: 10.1128/AAC.03570-14. Epub 2014 Aug 25.
10
[Nosocomial infection in patients receiving a solid organ transplant or haematopoietic stem cell transplant].[接受实体器官移植或造血干细胞移植患者的医院感染]
Enferm Infecc Microbiol Clin. 2014 Jun-Jul;32(6):386-95. doi: 10.1016/j.eimc.2014.05.002. Epub 2014 Jun 18.